November 18, 2025

A diverse clinical research team collaborating in a modern lab, representing progress in FDA leadership, equity in clinical trials, and inclusive drug development

What Dr. Richard Pazdur’s Appointment to FDA CDER Means for Equity in Clinical Research

Clinical Trials / Victor Mejia

Article Written By: Christina Edwards, MHA Director, Clinical Trials Center for Clinical and Social Research (CCSR) As someone committed to advancing equity and inclusion,working as the director of clinical […]

What Dr. Richard Pazdur’s Appointment to FDA CDER Means for Equity in Clinical Research Read More »

U.S. Drug Pricing Reform: Major Moves to Bring Down Costs for American Patients

Health Policy, Top Stories / Jessica Wilson

The United States has long confronted a troubling fact: Americans pay far more for brand-name prescription drugs than patients in other high-income nations. In fact, the administration recently stated that

U.S. Drug Pricing Reform: Major Moves to Bring Down Costs for American Patients Read More »